Answers are grounded in this paper and cite their sources.
Clinical study demonstrates high complication rates from exchange transfusion in ill newborns, suggesting thresholds for intervention should not be lowered.
Because of the significantly greater rate of severe complications in ill infants, exchange transfusion should be delayed until the risk of bilirubin encephalopathy is as high as the risks of severe complications from the procedure itself (12%). These results do not support recommendations to use lower exchange levels in ill infants compared with healthy infants.
No takes yet. Share an insight, caveat, or question.
J. Craig Jackson (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: